Treatment with Qing'E, a kidney-invigorating Chinese herbal formula, antagonizes the estrogen decline in ovariectomized mice

Rejuvenation Research

Volumn 13, Issue 4, 2010, Pages 479-488

  Xu, Ying ^a   Zhang, Zi Jia ^a,b   Geng, Fang ^a   Su, Shi Bing ^a   White, Kenneth N ^c   Bligh, S W Annie ^c   Branford White, Christopher J ^c   Wang, Zheng Tao ^a,b,c  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Shanghai R and D Centre for Standardization of Chinese Medicines   (China)

^c LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LUCIFERASE; QING E; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; ESTRUS CYCLE; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; RECTUM TEMPERATURE; RENAL PROTECTION; UTERUS ATROPHY; UTERUS DISEASE;

ADRENAL GLANDS; ANIMALS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ESTRADIOL; ESTRUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE; MICE; ORGAN SIZE; OVARIECTOMY; RECEPTORS, ESTROGEN; UTERUS;

MUS;

EID: 77956111437     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2009.1000     Document Type: Article

References (40)

1. Grady D. Postmenopausal hormones-therapy for symptoms only. N Engl J Med 2003;348:1839-1854.
2. Fernandez E, Gallus S, Bosetti C, Franceschi S, Negri E, La Vecchia C. Hormone replacement therapy and cancer risk: A systematic analysis from a network of case-control studies. Int J Cancer 2003;105:408-412.
3. Humphries KH, Gill S. Risks and benefits of hormone replacement therapy: The evidence speaks. Can Med Assoc J 2003;168:1001-1010.
4. Barone M, Tanzi S, Lofano K, Scavo MP, Guido R, Demarinis L, Principi MB, Bucci A, Di Leo A. Estrogens, phytoestro-gens and colorectal neoproliferative lesions. Genes Nutr 2008;3:7-13.
5. Benassayag C, Perrot-Applanat M, Ferre F. Phytoestrogens as modulators of steroid action in target cells. J Chromatogr B Analyt Technol Biomed Life Sci 2002;777:233-248.
6. Beck V, Rohr U, Jungbauer A. Phytoestrogens derived from redclover: an alternative to estrogen replacement therapy? J Steroid Biochem Mol Biol 2005;94:499-518.
7. FU XH. Treating the Climacteric Syndrome in the Kidney Theory. Chinese Journal of Basic Medicine in Traditional Chinese Medicine 2003;9:56-57.
8. S XM, Du Y, Shi X. The pathogenesis of climacteric syndrome and principle of acupuncture treatment based on TCM theory about brain. J Tradit Chin Med 2005;25:108-113.
9. National Pharmacopoeia Committee. China Pharmacopoeia. Chemical Industry Press, Beijing, 2005.
10. Shen L, Du JY, Yang JY, Yang YP, Gao L, Zhou PG. Qing'E pill treated 52 Cases of senile osteoporosis. Hubei Journal of Traditional Chinese Medicine 1994;109:16-18.
11. CDER. Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. FDA. Guidance for Industry, Pharmacology and Toxicology, Washington, DC, 2005.
12. Xu SY. Pharmacological Experiments Methodology, 2nd edition. Beijing People's Health Publishing House, Beij-ing,1991, p 1293.
13. Zhang H, Li HF, Yang NL. Efects of estrogen and phytoes-trogens on the morphology and ERa expression in breast tissue of ovariectomized rats. Chinese Pharmacolog Bull 2008;24:518-522.
14. Overk CR, Yao P, Chadwick LR, Nikolic D, Sun Y, Cuendet MA, Deng Y, Hedayat AS, Pauli GF, Farnsworth NR, van Breemen RB, Bolton JL. Comparison of the in vitro estro-genic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J Agric Food Chem 2005;53:6246-6253.
15. Liu H, Xu K, Tan J, Yang S. Effects of Nilestriol on reproductive system in ovariectomized rats. Hua Xi Yi Ke Da Xue Xue Ba. 2000;31:65-67.
16. Hill K: The demography of menopause. Maturitas 1996; 23:113-127.
17. Palacios S, Calaf J, Cano A, Parrilla JJ: Spanish Menopause Society (AEEM). Relevant results of the WHI study for the management of the menopause in Spain. Maturitas 2003; 44:83-86.
18. Mosconi P, Donati S, Colombo C, Mele A, Liberati A, Satolli R. Informing women about hormone replacement therapy: the consensus conference statement. BMC Women's Health 2009; 9:14.
19. Barnes, S. Phytoestrogens and breast cancer. Baillieres Clin Endocrinol Metab 1998;12:559-579.
20. Limer JL, Speirs V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res 2004;6:119-127.
21. Moon YJ, Wang X, Morris ME. Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism.Toxicol In Vitro 2006; 20:187-210.
22. Sirtori CR, Arnoldi A, Johnson SK. Phytoestrogens: End of a tale? Ann Med 2005;37:423-438.
23. Zhang ZJ, Liao LP, Moore J, Wu T, Wang ZT. Antioxidant phenolic compounds from walnut kernels (Juglans regia L.). Food Chem 2009;113:160-165.
24. Kojuri J, Vosoughi AR, Akrami M. Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis 2007;6:5.
25. Lemar KM, Passa O, Aon MA, Cortassa S, Müller CT, Plummer S, O'Rourke B, Lloyd D. Allyl alcohol and garlic (Allium sativum) extract produce oxidative stress in Candida albicans. Microbiology 2005;151:3257-3265.
26. Micevych P, Soma KK, Sinchak K. Neuroprogesterone: Key to estrogen positive feedback? Brain Res Rev 2008;57: 470-480.
27. Rimoldi G, Christoffel J, Seidlova-Wuttke D, Jarry H, Wuttke W. Effects of chronic genistein treatment in mammary gland, uterus, and vagina. Environ Health Perspect 2007;115:62-68.
28. Shao W, Keeton EK, McDonnell DP, Brown M. Coactivator AIB1 links estrogen receptor transcriptional activity and stability. Proc Natl Acad Sci USA 2004;101:11599-11604.
29. Hou J, Xiong XY, MiM. Efects of xy9902 on the proliferation and differentiation of MC3T-EI cells. Chin Pharmacol Bull 2006;22:529-532.
30. Green S, Chambon P.A superfamily of potentially oncogenic hormone receptors. Nature 1986; 324:615-617.
31. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925-5930.
32. Mosselman S, Polman J, Dijkema R. ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett 1996;392:49-53.
33. Pelletier G, Labrie C, Labrie F. Localization of oestrogen receptor alpha, oestrogen receptor beta and androgen receptors in the rat reproductive organs. J Endocrinol 2000; 165:359-370.
34. Saunders PT, Maguire SM, Gaughan J, Millar MR. Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry. J Endocrinol 1997;154:R13-R16.
35. Shughrue PJ, Lane MV, Scrimo PJ, Merchenthaler I. Comparative distribution of estrogen receptor-alpha (ERalpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 1998;63:498-504.
36. Darbre PD, Daly RJ. Effects of oestrogen on human breast cancer cells in culture. Proc R Soc Edinburgh B 1989;95B: 119-132.
37. Byford JR, Shaw LE, Drew MGB, Pope GS, Sauer MJ, Darbre PD. Oestrogenic activity of parabens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2002;80:49-60.
38. Matsumura A, Ghosh A, Pope GS, Darbre PD. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 2005;94:431-443.
39. Oseni T, Patel R, Pyle J, Jordan VC. Selective estrogen receptor modulators and phytoestrogens. Planta Med 2008;74: 1656-1665.
40. Xin D, Wang H, Yang J, Su Y-F, Fan G-W, Wang Y-F, Zhu Y, Gao X-M. Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity. Phytomed 2010;17: 126-131.